GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Egetis Therapeutics AB (OSTO:PLED BTA) » Definitions » Receivables Turnover

Egetis Therapeutics AB (OSTO:PLED BTA) Receivables Turnover : 0.72 (As of Mar. 2025)


View and export this data going back to . Start your Free Trial

What is Egetis Therapeutics AB Receivables Turnover?

The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Egetis Therapeutics AB's Revenue for the three months ended in Mar. 2025 was kr12.70 Mil. Egetis Therapeutics AB's average Accounts Receivable for the three months ended in Mar. 2025 was kr17.60 Mil. Hence, Egetis Therapeutics AB's Receivables Turnover for the three months ended in Mar. 2025 was 0.72.


Egetis Therapeutics AB Receivables Turnover Historical Data

The historical data trend for Egetis Therapeutics AB's Receivables Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Egetis Therapeutics AB Receivables Turnover Chart

Egetis Therapeutics AB Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Receivables Turnover
Get a 7-Day Free Trial Premium Member Only Premium Member Only 8.95 10.38 6.16 3.60 2.11

Egetis Therapeutics AB Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Receivables Turnover Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.46 0.61 0.44 0.57 0.72

Competitive Comparison of Egetis Therapeutics AB's Receivables Turnover

For the Biotechnology subindustry, Egetis Therapeutics AB's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Egetis Therapeutics AB's Receivables Turnover Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Egetis Therapeutics AB's Receivables Turnover distribution charts can be found below:

* The bar in red indicates where Egetis Therapeutics AB's Receivables Turnover falls into.


;
;

Egetis Therapeutics AB Receivables Turnover Calculation

Receivables Turnover measures the number of times a company collects its average accounts receivable balance.

Egetis Therapeutics AB's Receivables Turnover for the fiscal year that ended in Dec. 2024 is calculated as

Receivables Turnover (A: Dec. 2024 )
=Revenue / Average Accounts Receivable
=Revenue (A: Dec. 2024 ) / ((Accounts Receivable (A: Dec. 2023 ) + Accounts Receivable (A: Dec. 2024 )) / count )
=46.1 / ((28.2 + 15.5) / 2 )
=46.1 / 21.85
=2.11

Egetis Therapeutics AB's Receivables Turnover for the quarter that ended in Mar. 2025 is calculated as

Receivables Turnover (Q: Mar. 2025 )
=Revenue / Average Accounts Receivable
=Revenue (Q: Mar. 2025 ) / ((Accounts Receivable (Q: Dec. 2024 ) + Accounts Receivable (Q: Mar. 2025 )) / count )
=12.7 / ((15.5 + 19.7) / 2 )
=12.7 / 17.6
=0.72

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Egetis Therapeutics AB  (OSTO:PLED BTA) Receivables Turnover Explanation

An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.


Egetis Therapeutics AB Receivables Turnover Related Terms

Thank you for viewing the detailed overview of Egetis Therapeutics AB's Receivables Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.


Egetis Therapeutics AB Business Description

Traded in Other Exchanges
Address
Grev Turegatan 11 C, Stockholm, SWE, 114 46
Egetis Therapeutics AB is an integrated pharmaceutical drug development company, focusing on projects in late-stage development for the treatment of serious rare/niche diseases with unmet medical needs in the orphan drug segment.

Egetis Therapeutics AB Headlines

No Headlines